Does Laterality of Positive Needle Biopsy in Clinical T2a Patients With Prostate Cancer Affect Biochemical Recurrence-Free Survival?

The laterality of the needle biopsy in relation to the palpable abnormality in patients with clinical Stage T2a could affect BRFS. Our data have demonstrate an insignificant difference between patients with cT2a contralateral disease and those with contralateral cT1c disease.